-
Mashup Score: 0In memoriam: A tribute to Dr Scott M. Grundy - 21 day(s) ago
Dr Scott Grundy, a legendary clinician scientist in atherosclerotic cardiovascular disease and cardiometabolic disease, recently died at age 91 on January 29, 2025. This memorial is written by several of his innumerable colleagues, each of whom worked with Scott during his long and distinguished career. He will be remembered gratefully and with the highest esteem by all of us in the fields of lipid metabolism, diabetes, nutrition, and cardiovascular disease for:
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Lipid-lowering efficacy of obicetrapib: A comprehensive systematic review and meta-analysis - 26 day(s) ago
The primary function of cholesteryl ester transfer protein (CETP) is to facilitate the transfer of cholesteryl esters and triglycerides between lipoproteins. CETP inhibitors reduce the transfer of cholesterol from high-density lipoprotein (HDL) particles to low-density lipoprotein (LDL) and very low-density lipoprotein particles (VLDL). This results in elevated HDL-C levels and a decrease in LDL-C, non-HDL-C, and apolipoprotein B (ApoB) levels.1 Observational studies have demonstrated that certain reduced-function polymorphisms of CETP are associated with a decrease in major adverse cardiovascular events (MACE) and mortality.
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
Lipid-lowering efficacy of #obicetrapib: A #metaanalysis https://t.co/ZKmXvTs2e9
-
-
Mashup Score: 1Lipidology: The Time is Now for Specialty Recognition - 1 month(s) ago
On May 2, 2024, the National Lipid Association (NLA) submitted its request to the National Uniform Claim Committee for a new Health Care Provider Taxonomy code for “Lipidology,”1 which, if endorsed, would initially apply to physicians practicing the specialty of clinical lipidology. The rationale for this request lies in the characteristics of lipidology as a complex sub-specialty encompassing diverse fields of medicine, such as Family Medicine, Internal Medicine, Obstetrics & Gynecology, Pediatrics, Cardiology, Endocrinology, Obesity Medicine, and Preventive/Lifestyle Medicine, but with features that are unique from these parent specialties.
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
To kick off #AmericanHeartMonth, we begin with sharing our recent statement on the importance of a lipid specialty taxonomy code. Check out some key quotes from "Lipidology: The Time is Now for Specialty Recognition", published in JCL. Read the article: https://t.co/TXQFEWwo4s https://t.co/oKsxI7yvin
-
-
Mashup Score: 19Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association - 1 month(s) ago
In 2014-2015, the National Lipid Association (NLA) published Recommendations for Patient-Centered Management of Dyslipidemia Parts 1 and 2 to provide in-depth clinical guidance for the assessment and treatment of dyslipidemias in adults.1,2 Since then, other scientific organizations have published guidelines and recommendations for the prevention and management of atherosclerotic cardiovascular disease (ASCVD).3-8 However, nutrition recommendations in those documents typically address ASCVD prevention, in general, rather than nutrition interventions for the management of specific dyslipidemias.
Source: www.lipidjournal.comCategories: General Medicine News, General HCPsTweet-
Emphasize the following foods and components to reduce atherosclerotic cardiovascular disease risk: 🍎 fruits 🥕 vegetables 🍞 whole grains 🥜 nuts 🐠 🦞 fish and seafood 🥛 low fat dairy products 🫒 non-tropical plant oils https://t.co/pOmJsrOL5g https://t.co/uoTp1GoeBl
-
-
Mashup Score: 6Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection - 3 month(s) ago
Persons with human immunodeficiency virus (HIV) (PWH) have an approximately 2-fold increased risk of developing cardiovascular disease (CVD) than those without HIV (PWoH).1,2 This increased CVD risk may be due to chronic systemic inflammation and immune activation in PWH.3 Lipoprotein (a) (Lp(a)), a subclass of low-density lipoprotein (LDL), is an independent atherosclerotic risk factor in PWoH.4,5 While elevated Lp(a) levels may occur in PWH,6 few studies have investigated the association of Lp(a) and subclinical atherosclerosis,7,8 and no studies have evaluated its association with peri-coronary inflammation.
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
Check out new research on Lp(a) & Coronary Inflammation @ShanaABB @LipidJournal @nationallipid @PennMedicine @PennCardiology @washumedicine @UMmedschool @ASPCardio https://t.co/97Hvpf8tYr https://t.co/wU5s02zoWE
-
-
Mashup Score: 6Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association - 3 month(s) ago
Summary of key points
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/Lc4elGTkv8
-
-
Mashup Score: 24Lipidology: The Time is Now for Specialty Recognition - 3 month(s) ago
On May 2, 2024, the National Lipid Association (NLA) submitted its request to the National Uniform Claim Committee for a new Health Care Provider Taxonomy code for “Lipidology,”1 which, if endorsed, would initially apply to physicians practicing the specialty of clinical lipidology. The rationale for this request lies in the characteristics of lipidology as a complex sub-specialty encompassing diverse fields of medicine, such as Family Medicine, Internal Medicine, Obstetrics & Gynecology, Pediatrics, Cardiology, Endocrinology, Obesity Medicine, and Preventive/Lifestyle Medicine, but with features that are unique from these parent specialties.
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
Lipidology: The Time is Now for Specialty Recognition https://t.co/7OE9mlUlTz
-
-
Mashup Score: 11Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America - 4 month(s) ago
Familial chylomicronemia syndrome (FCS) is an ultrarare inherited disorder. Genetic testing is not always feasible or conclusive. European clinicians developed a “FCS score” to differentiate between FCS and multifactorial chylomicronemia syndrome (MCS), a more common condition with overlapping features. A diagnostic score has not been developed for use in the North American context.
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America - Journal of Clinical Lipidology https://t.co/ECGfxYoSNR via @LipidJournal @nationallipid please share @NYUCVDPrevent @Drlipid @FamilyHeartFdn @foundationofnla… https://t.co/Fxsiuzjzhp
-
-
Mashup Score: 4Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease - 4 month(s) ago
Lipoprotein(a) is an independent and causal risk factor for coronary heart disease (CHD).1 More effective therapies are needed in the secondary prevention of CHD, with >40 % of CHD events occuring in those with established CHD.2 Lp(a) has thus emerged as a promising therapeutic target in the secondary prevention of CHD.3
Source: www.lipidjournal.comCategories: General Medicine News, CardiologistsTweet-
https://t.co/Rbhk8DqAXk
-
-
Mashup Score: 11Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis - 6 month(s) ago
Cerebrotendinous xanthomatosis (CTX) is a rare disorder due to defective sterol 27-hydroxylase causing a lack of chenodeoxycholic acid (CDCA) production and high plasma cholestanol levels.
Source: www.lipidjournal.comCategories: General Medicine News, Cardiology News and JournTweet-
#SpotlightSunday: This @lipidjournal article on 43 cases of cerebrotendinous xanthomatosis offers crucial insights into diagnosis & treatment of this rare disorder. Another must-read for those managing complex lipid conditions 🔗https://t.co/XQXNhlFsZE #LipidXcellence https://t.co/7tgrnxbUdR
-
In memoriam: A tribute to Dr Scott M. Grundy - Journal of Clinical Lipidology https://t.co/eGkmUvcTPP